[논문]A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson’s disease

Kokubo, Naomi; Yokoi, Yuma; Saitoh, Yuji; Murata, Miho; Maruo, Kazushi; Takebayashi, Yoshitake; Shinmei, Issei; Yoshimoto, Sadanobu; Horikoshi, Masaru

doi:10.1186/s12888-018-1795-7

A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson’s disease 원문보기

BMC psychiatry, v.18, 2018년, pp.220 -

Kokubo, Naomi (Translational Medical Center, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, 187-8551 Japan) , Yokoi, Yuma (Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan) , Saitoh, Yuji (Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan) , Murata, Miho (Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan) , Maruo, Kazushi (Faculty of Medicine, University of Tsukuba, Ibaraki, Japan) , Takebayashi, Yoshitake (National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry, Tokyo, Japan) , Shinmei, Issei (National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry, Tokyo, Japan) , Yoshimoto, Sadanobu (National Institute of Technology, Tokyo College, Tokyo, Japan) , Horikoshi, Masaru (National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry, Tokyo, Japan)

Abstract ▼ AI-Helper

BackgroundA newer generation neuropsychological tests can take advantage of touch screen and mobile technology. We have developed a new Android application termed “User eXperience-Trail Making Test (UX-TMT)” for neurocognitive assessment and training. This study investigated the utility, including the reliability and the validity, of the UX-TMT as a screening test for cognitive decline in adults.MethodsA total of 84 individuals aged 27–86 years were divided into three groups; healthy controls ([HC] n = 29), people with Parkinson’s disease (PD; n = 28), and people with mild cognitive impairment (MCI) and dementia (MCI&D; n = 27). We examined the distributions of the scores and the time required, and the effects of age and group on these distributions. We analyzed internal consistency and convergent validity in all samples and applied receiver operator characteristic (ROC) analysis to determine a cutoff score that could differentiate the MCI & D group from the HC group.Results97.6% of the participants completed all of the tasks, and the average total test time required for UX-TMT was 428.8 (± 109.1) s in the HC, 542.0 (± 168.7) s in the PD, and 777.5 (± 256.1) s in the MCI&D groups, respectively. The MCI&D group showed significantly lower UX-TMT scores and longer total time in completing the task than the HC group. In an ROC analysis, a score of 21 showed high sensitivity (.83) and specificity (.92), and the UX-TMT score plus age improved sensitivity to .96. Additionally, the UX-TMT scores showed significant correlation with the Mini-Mental State Examination (Japanese version) scores (r = .77, p = .001), and Cronbach’s alpha (.71–.83) indicated acceptable internal consistency.ConclusionThe UX-TMT demonstrated high reliability and validity to detect cognitive decline in Japanese adults, highlighting its utility as a screening tool for epidemiological and clinical research.

주제어

참고문헌 (47)

1. United Nations World population aging 2015
2. Johnson IP Age-related neurodegenerative disease research needs aging models Front Aging Neurosci 2015 7 168 10.3389/fnagi.2015.00168 26388766

상세보기
3. Prince M Bryce R Albanese E Wimo A Ribeiro W Ferri CP The global prevalence of dementia: a systematic review and meta-analysis Alzheimers Dement 2013 9 63 75 10.1016/j.jalz.2012.11.007 23305823

상세보기
4. Ferencz B Gerristen L Genetics and underlying pathology of dementia Neuropsychol Rev 2015 25 113 124 10.1007/s11065-014-9276-3 25567624

상세보기
5. Adams HHH Bruijn RFAG Hofman A Uitterlinden AG Duijn CM Vernooij MW Koudstaal PJ Ikram MA Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia Alzheimers Dement 2015 11 1277 1285 10.1016/j.jalz.2014.12.008 25916564

상세보기
6. Aerts L Heffernan M Kochan NA Crawford JD Draper B Trollor JN Sachdev PS Brodaty H Effects of MCI subtype and reversion on progression to dementia in a community sample Neurology 2017 88 1 8 10.1212/WNL.0000000000004015 28025394

상세보기
7. Petersen RS Caraccio B Brayne C Gauthier S Jelic V Fratiglioni L Mild cognitive impairment: a concept in evolution J Intern Med 2014 275 3 214 228 10.1111/joim.12190 24605806

상세보기
8. Cheng YW Chen TF Chiu MJ From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution Neuropsychiatr Dis Treat 2017 13 491 498 10.2147/NDT.S123428 28243102

상세보기
9. Dorsey ER Constantinescu R Thompson JP Biglan KM Holloway RG Kieburtz K Marshall FJ Ravina BM Schifitto G Siderowf A Tanner CM Projected number of people with parkinson disease in the most populous nations, 2005 through 2030 Neurology 2007 68 384 386 10.1212/01.wnl.0000247740.47667.03 17082464

상세보기
10. Aarsland D Creese B Politis M Chaudhuri KR Ffytche DH Weintraub D Cognitive decline in Parkinson disease Nat Rev Neurol 2017 13 4 217 231 10.1038/nrneurol.2017.27 28257128

상세보기
11. Litvan I Goldman JG Troster AI Schmand BA Weintraub D Petersen RC Mollenhauer B Aarsland D Kulisevsky J Rodriguez-Oroz MC Burn DJ Barker RA Murat E Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines Mov Disord 2012 27 3 349 356 10.1002/mds.24893 22275317

상세보기
12. Hoogland J Boel JA de Bie RMA Geskus RB Schmand BA Dalrymple-Alford JC Marras C Adler CH Goldman JG Troster AI Burn DJ Litvan I Geurtsen GJ Mild Cognitive Impairment as a risk factor for parkinson’s disease dementia 2017 1056 1065
13. Emre M Arsland D Brown R Burn DJ Duyckaerts C Mizuno Y Broe GA Cummings J Dickson DW Gauthier S Goldman J Goetz C Korczyn A Lass A Levy R Litvan I McKeith I Olanow W Poewe W Quinn N Sampaio C Tolosa E Dubois B Clinical diagnostic criteria for dementia associated with Parkinson’s disease Mov Disord 2007 22 12 1689 1707 10.1002/mds.21507 17542011

상세보기
14. Pedersen KF Larsen JP Tysnes OB Alves G Natural course of mild cognitive impairment in Parkinson disease Neurology 2017 88 767 774 10.1212/WNL.0000000000003634 28108638

상세보기
15. Brookmeyer R Johnson E Graham KZ Arrighi HM Forecasting the global burden of Alzheimer’s disease Alzheimers Dement 2007 3 186 191 10.1016/j.jalz.2007.04.381 19595937

상세보기
16. Baumgart M Snyder HM Carrillo MC Sam F Kim H Johns H Summary of the evidence on risk factors for cognitive decline and dementia: a population-based perspective Alzheimers Dement 2015 11 6 718 726 10.1016/j.jalz.2015.05.016 26045020

상세보기
17. Ngandu T Lehtisalo J Solomon A Levalahti E Ahtiluoto S Antikainen R Backman L Hanninen T Jula A Laatikainen T Lindstorm J Mangialasche F Paajanen T Pajala S Peltonen M Rauramaa R Stigsdotter-Neely A Stranberg T Tuomilehto J Soininen H Kivipelto M A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial Lancet 2015 385 9984 2255 2263 10.1016/S0140-6736(15)60461-5 25771249

상세보기
18. Svenningsson P Westman E Bllard C Aarsland D Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment Lancet Neurol 2012 11 697 707 10.1016/S1474-4422(12)70152-7 22814541

상세보기
19. Leung IHK Walton CC Lewis SJG Valenzuela M Lampit A Cognitive training in Parkinson disease: a systematic review and meta-analysis Neurology 2015 85 21 1843 1851 10.1212/WNL.0000000000002145 26519540

상세보기
20. Honda M Hashimoto K Miyamura K Goto H Abo M Validity and reliability of a computerized cognitive assessment tool ‘higher brain functional balancer’ for healthy elderly people. Jpn J Cogn Neurosci 2010 12 3–4 191 197
21. Onoda K Hamano T Nabika Y Aoyama A Takayoshi H Nakagawa T Ishihara M Mitaki S Yamaguchi T Oguro H Shiwaku K Yamaguchi S Validation of a new mass screening tool for cognitive impairment: cognitive assessment for dementia, iPad version Clin Interv Aging 2013 8 353 360 10.2147/CIA.S42342 23569368

상세보기
22. Brouillette RM Foil H Fontenot S Correro A Allen R Martin KC Bruce-Keller AJ Keller JN Feasibility, reliability, and validity of a smartphone based application for the assessment of cognitive function in elderly PLoS One 2013 8 6 e65925 10.1371/journal.pone.0065925 23776570

상세보기
23. Onoda K Yamaguchi S Revision of the cognitive assessment for dementia, iPad version (CADi2) PLoS One 2014 9 10 e109931 10.1371/journal.pone.0109931 25310860

상세보기
24. Park HY Jeon SS Lee JY Cho AR Park JH Korean version of the mini-mental state examination using smartphone: a validation study Telemed JE Health 2017 23 10 815 821 10.1089/tmj.2016.0281

상세보기
25. Kokubo N Inagaki M Gunji A Kobayashi T Ohta H Kajimoto O Kaga M Developmental change of visuo-spatial working memory in children: quantitative evaluation through an advanced trail making test Brain and Development 2012 34 10 799 805 10.1016/j.braindev.2012.02.001 22398277

상세보기
26. Fellows RP Dahmen J Cook D Edgecombe MS Multicomponent analysis of a digital trail making test Clin Neuropsychol 2017 31 1 154 167 10.1080/13854046.2016.1238510 27690752

상세보기
27. Dodge HH Zhu J Mattek NC Austin D Kornfeld J Kaye AJ Use of high-frequency in home-monitoring data may reduce sample size needed in clinical trials PLoS One 2015 10 9 e0138095 10.1371/journal.pone.0138095 26379170

상세보기
28. Kokubo N Atsumi R Kawakubo R Goto K Shibata N Taira M Morohoshi S Yoshimoto S Asano K Aoki H Development of android application “user eXperience-trail making test: UX-TMT” for the neurocognitive assessment and training through medicine engineering collaboration The 1st annual meeting for cognitive enhancement in psychiatric disorders 2015
29. Melnick ER Hess EP Guo G Breslin M Lopez K Pavlo AJ Abujarad F Powsner SM Post LA Patient-centered decision support: formative usability evaluation of integrated clinical decision support with a patient decision aid for minor head injury in the emergency department J Med Internet Res 2017 19 5 e174 10.2196/jmir.7846 28526667

상세보기
30. Yasumura A Kokubo N Yamamoto H Yasumura Y Nakagawa E Kaga M Hiraki K Inagaki M Neurobehavioral and hemodynamic evaluation of Stroop and reverse Stroop interference in children with attention-deficit/hyperactivity disorder Brain and Development 2014 36 2 97 106 10.1016/j.braindev.2013.01.005 23414618

상세보기
31. Baker E Iqbal E Johnston C Broadbent M Shetty H Stewart R Howard R Newhouse S Khondoker M Dobson RJ Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohort PLoS One 2017 12 6 e0178562 10.1371/journal.pone.0178562 28591196

상세보기
32. Sugishita M Hemmi I Takeuchi T Reexamination of the validity and reliability of the Japanese version of the mini-mental state examination (MMSE-J) Japanese Journal of Cognitive Neuroscience 2016 18 168 183
33. Nasreddine ZS Phillips NA Bedirian V Charbonneau S Whitehead V Collin I Cummings JL Chertkow H The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 2005 53 695 699 10.1111/j.1532-5415.2005.53221.x 15817019

상세보기
34. Suzuki H Fujiwara Y Development of the Japanese version of Montreal cognitive assessment (MoCA) and the utility Japanese Journal of Geriatric Psychiatry 2010 21 2 198 202
35. Ware J Jr Kosinski M Keller SD A 12-item short form health survey: construction of scales and preliminary tests of reliability and validity Med Care 1996 34 3 220 233 10.1097/00005650-199603000-00003 8628042

상세보기
36. Watson D Clark LA Tellegen A Development and validation of brief measures of positive and negative affect: the PANAS scales J Pers Soc Psychol 1988 54 1063 1070 10.1037/0022-3514.54.6.1063 3397865

상세보기
37. Kawahito J Ohtsuka Y Kaida K Nakata A Reliability and validity of the Japanese version of 20-item positive and negative affect schedule Hiroshima psychological research 2011 11 225 240
38. The Japan Geriatric Society: https://www.jpn-geriat-soc.or.jp/tool/tool_02.html . Accessed 6 Sept 2017.
39. Seelye A Mattek N Reynolds C Sharma N Wild K Kaye J The Survey for Memory, Attention, and Reaction Time (SMART): A Brief Online Personal Computing Based Cognitive Assessment for Healthy Aging and Mild Cognitive Impairment. Abstract ID: a18921 2017 London Alzheimer’s Association International Conference
40. Maruff P Petersen RC Aisen PS Weiner M Albala B Acceptability, Usability, Validity and Sensitivity of Cognition Assessed in Unsupervised Settings. Abstract ID: a16958 2017 London Alzheimer’s Association International Conference
41. Pedraza O Clark JH O’Bryant SE Smith GE Ivnik RJ Graff-Radforf NR Willis FB Petersen RC Lucas JA Diagnostic validity of age- and education-corrections for the mini-mental state examination (MMSE) in African American elders J Am Geriatr Soc 2012 60 2 328 331 10.1111/j.1532-5415.2011.03766.x 22150301

상세보기
42. Piccinin AM Terrera GM Clouston S Reynolds CA Thorvaldsson V Deary IJ Deeg DJH Johansson B Mackinnon A Spiro A III Starr JM Skoog I Hofer SM Coordinated analysis of age, sex, and education effects on change in MMSE scores Psychological Sciences and Social Sciences 2013 68 3 374 390 10.1093/geronb/gbs077 23033357

상세보기
43. Freitas S Simone MR Alves L Santana I The relevance of sociodemographic and health variables on MMSE normative data Applied Neuropsychology: Adult 2015 22 311 319 10.1080/23279095.2014.926455 25531579

상세보기
44. Zawadka-Kunikowska M Zalewski P Klawe JJ Pawlak J Tafil-Klawe M Kedziora-Kornatowska K Newton JL Age-related changes in cognitive function and postural control in Parkinson's disease Aging Clin Exp Res 2014 26 505 510 10.1007/s40520-014-0209-z 24691816

상세보기
45. Hauser RA Stocchi F Rascol O Huyck SB Capece R Ho TW Sklar P Lines C Michelson D Hewitt D Preladenant as an adjunctive therapy with levodopa in parkinson disease. Two randomized clinical trials and lessons learned JAMA neurol 2015 72 12 1491 1500 10.1001/jamaneurol.2015.2268 26523919

상세보기
46. Ahmad F Jhajj AK Stewart DE Burghardt M Bierman AS Single item measures of self-rated mental health: a scoping review BMC Health Serv Res 2014 14 398 10.1186/1472-6963-14-398 25231576

상세보기
47. Jenkins A Lindsay S Eslambolchilar P Thornton IM Tales A Administering cognitive tests through touch screen tablet devices: potential issues J Alzheimers Dis 2016 54 3 1169 1182 10.3233/JAD-160545 27567875

상세보기

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson’s disease 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (47)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

연관된 기능

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트